March 2026: Healthcare M&A Snapshot

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in March 2026 below.

Download Report

Notable Sector Deals: March 2026

Mayden’s acquisition of Wellola

• Another bolt-on deal for G Square-backed Mayden with the acquisition of Wellola, which is best known for its Portasana® patient engagement platform

• Portasana® is a fully integrated patient engagement platform that supports NHS and international healthcare providers in improving access, enabling safe self-management, and reducing pressure on clinical teams

• The platform connects with EPRs, the NHS App and wider clinical systems and is a natural diversification for Mayden from its core EPR offering

• The deal is Mayden’s third since securing investment from G Square in 2023, as the business continues to diversify its portfolio of digital products

Imbiba’s investment into Pindrop Hearing

• An interesting investment for Imbiba, backing private clinical audiology business, Pindrop Hearing

• Pindrop currently operates three premium locations at Harley Street, Chelsea and Winchmore Hill

• Imbiba’s investment will support the roll-out of clinics across London and the South of England, with Jonathan Gardner, the former MD of Boots Hearingcare, joining as Chairman

• The deal shows continued investor interest in the growing audiology market, following YFM’s buyout of Audiological Science last year

Acquisition of Eastbourne Vision by OCL Vision

• OCL Vision has acquired Eastbourne Vision, a specialist practice founded by consultant ophthalmic surgeon Shahram Kashani

• The acquisition marks OCL Vision’s first transaction since securing investment from BGF in 2025

• Eastbourne Vision has a strong reputation for cataract and specialist ophthalmic care, serving patients across East Sussex and the Sussex region

• The business will join OCL’s growing network of specialist eye surgery clinics, benefiting from enhanced clinical expertise, technology and infrastructure

• The deal supports OCL Vision’s strategy to expand its UK clinical network and increase access to specialist eye care services

Fortava’s acquisition of 3 homes from Medina Groups

• Downing-backed Fortava Healthcare has completed the acquisition of three dementia care homes in Nottingham

• The acquisitions increase Fortava’s total capacity to 322 beds, strengthening its position in the specialist dementia care market

• The deal forms part of Fortava’s ongoing buy-and-build strategy under Downing’s ownership

• The newly acquired homes are focused on high-quality dementia care provision, aligning with Fortava’s specialist operating model

• The deal highlights investor appetite for specialist care assets, particularly in dementia, where demand remains structurally strong and supply constrained

Healthcare Market Activity: March 2026

Private Equity Activity

Sub-sector	Target	Acquirer / Investor	Exiting PE
Clinical Services	Herts & Essex Fertility Centre	FutureLife (CVC)	N/A
Clinical Services	Pindrop Hearing	Imbiba	N/A
Digital Health	Wellola	Mayden (G Square)	N/A
Ophthalmology	Eastbourne Vision	OCL Vision (BGF)	N/A
Pharma Services	Dolon	Prescient (Bridgepoint)	N/A
Pharma Services	Seda Pharma Development Services	BGF	N/A
Specialist Care	3 homes from Medina Groups	Fortava Healthcare (Downing)	N/A
Veterinary	Swale Barn Vets	Kin Vet Community (Perwyn)	N/A

Venture Capital Activity

Target	Description	Lead Investor	Investment
Antiverse	Antibody discovery platform	Soulmates Ventures	£7m
Cirdan	LIS & imaging solutions	Invest NI*	£12.9m
Combat Medical	Devices for delivery of cancer therapeutics	T&J Meyer Family Foundation	£2.6m
Flexzo AI	Agentic workforce system for healthcare providers	Octopus Ventures	£8.9m
IQ Endoscopes	Single use endoscopes	BGF Development Bank of Wales	N/A
Spotlight Pathology	AI-powered tools for diagnosing blood cancer	Liverpool City Region Seed Fund	£1.4m
Ternary Therapeutics	AI platform to create molecular glues	Daphni	£3.6m